Soru

Zorluk: KolayHematology and Oncology

During a routine clinic visit, a 62-year-old male veteran complains of severe, widespread itching that reliably occurs within minutes of stepping out of a warm shower. He also reports recent onset of headaches and a sensation of fullness in his head. Physical examination reveals a ruddy facial complexion and a palpable spleen edge extending 33 cm below the left costal margin. Laboratory studies reveal:

TestValue
Hemoglobin19.219.2 g/dL
Leukocytes14,20014,200/mm³
Platelets550,000550,000/mm³

Which of the following is the most appropriate next diagnostic step for this patient?

  1. A
    Arterial blood gas measurement
  2. B
    Initiation of broad-spectrum antibiotics
  3. Peripheral blood mutation analysis for JAK2Cevap
  4. D
    Bone marrow aspiration and biopsy
  5. E
    Reassurance and oral fluid hydration

Cevap

Peripheral blood mutation analysis for JAK2 is the most appropriate next diagnostic step to confirm suspected Polycythemia Vera.
The patient's presentation of aquagenic pruritus (itching specifically after hot showers), facial plethora, splenomegaly, and panmyelosis (elevated erythrocytes, leukocytes, and platelets) is the classic triad of findings for Polycythemia Vera (PV). PV is a clonal myeloproliferative disorder driven primarily by a somatic mutation in the Janus kinase 2 (JAK2) gene, resulting in constitutive tyrosine kinase activity and EPO-independent proliferation of myeloid cells. The most appropriate initial diagnostic step is peripheral blood testing for the JAK2 V617F mutation (present in >95%>95\% of cases), typically ordered alongside a serum erythropoietin level (which would be low).

Adım Adım Çözüm

1
Identify the clinical syndrome from the patient's presentation and lab findings.
The patient exhibits aquagenic pruritus, facial plethora, splenomegaly, and panmyelosis (simultaneous elevation of red blood cells, white blood cells, and platelets).
Recognizing this combination of findings correctly points toward a myeloproliferative neoplasm rather than a reactive or secondary process.
2
Determine the appropriate initial diagnostic sequence for the suspected condition.
The most accurate, non-invasive initial test for Polycythemia Vera is peripheral blood testing for a JAK2 mutation.
The JAK2 V617F mutation is present in over 95% of patients with Polycythemia Vera. Testing for this mutation in the peripheral blood avoids immediate invasive procedures like bone marrow biopsy.

Anahtar Kavram

Polycythemia vera presents with hyperviscosity symptoms, aquagenic pruritus, splenomegaly, and panmyelosis, and is initially diagnosed via non-invasive peripheral blood JAK2 mutation analysis.
Bu soruyu puanla